Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,99.99,10/07/2015,GNRL,295000822
95528,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,69.00,09/17/2013,GNRL,31913778
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,65.03,04/14/2015,GNRL,332296981
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,59.19,01/16/2015,GNRL,260111548
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,25.00,12/09/2015,GNRL,318640428
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,24.89,04/02/2014,GNRL,168759290
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.45,01/24/2014,GNRL,187742398
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,22.94,10/02/2013,GNRL,111785362
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,21.17,02/10/2014,GNRL,160899420
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.15,06/25/2014,GNRL,148465716
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.73,04/04/2015,GNRL,260121942
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,20.67,10/27/2014,GNRL,156772312
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.67,06/09/2015,GNRL,269765130
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.25,09/25/2013,GNRL,32303991
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.80,11/20/2013,GNRL,12296667
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.76,05/28/2015,GNRL,331663337
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.47,07/27/2015,GNRL,331796815
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.27,09/18/2015,GNRL,331956131
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.20,04/29/2015,GNRL,290274256
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,19.12,11/12/2013,GNRL,111803104
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,18.92,03/19/2015,GNRL,331569321
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.85,06/18/2014,GNRL,196138904
95528,GNRL,"LILLY USA, LLC",IN,100000000066,18.67,12/09/2013,GNRL,100100726
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,18.42,09/03/2014,GNRL,188050840
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.35,08/16/2013,GNRL,103326092
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.28,04/10/2015,GNRL,337078604
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.71,12/12/2014,GNRL,188182436
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.68,12/21/2015,GNRL,290274246
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.62,03/01/2015,GNRL,269606566
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.53,02/03/2014,GNRL,196138916
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.49,10/12/2015,GNRL,332049675
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.46,09/06/2013,GNRL,104432026
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.41,10/07/2015,GNRL,318640454
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.33,10/06/2014,GNRL,198738342
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.20,04/28/2015,GNRL,339623588
95528,GNRL,"AbbVie, Inc.",IL,100000000204,16.94,09/06/2013,GNRL,104616212
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.94,11/06/2015,GNRL,339613434
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.90,01/09/2015,GNRL,331487787
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.88,02/21/2014,GNRL,196138914
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.69,12/03/2015,GNRL,275721772
95528,GNRL,"AbbVie, Inc.",IL,100000000204,16.67,03/05/2014,GNRL,189198320
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.59,09/23/2015,GNRL,290274250
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.48,11/16/2014,GNRL,162229920
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.48,05/11/2015,GNRL,294867506
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.44,10/28/2014,GNRL,188125442
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.39,07/30/2014,GNRL,161752566
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.28,03/30/2015,GNRL,260026712
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.28,10/14/2015,GNRL,275721768
95528,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.26,09/24/2013,GNRL,100859964
95528,GNRL,"Lilly USA, LLC",IN,100000000066,16.20,06/10/2015,GNRL,268121322
95528,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.14,06/27/2014,GNRL,199575662
95528,GNRL,"AbbVie, Inc.",IL,100000000204,16.01,11/14/2014,GNRL,189602830
95528,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.91,10/28/2013,GNRL,31913782
95528,GNRL,"Lilly USA, LLC",IN,100000000066,15.89,11/17/2015,GNRL,268121326
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.85,04/21/2015,GNRL,269713034
95528,GNRL,"Pfizer Inc.",NY,100000000286,15.78,10/31/2014,GNRL,206775180
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.75,12/16/2013,GNRL,32303988
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.62,09/15/2015,GNRL,290274252
95528,GNRL,"LILLY USA, LLC",IN,100000000066,15.60,12/20/2013,GNRL,100098356
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.58,11/25/2015,GNRL,270246706
95528,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.56,10/11/2013,GNRL,31913780
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.30,08/26/2015,GNRL,318640399
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.19,07/09/2014,GNRL,156772332
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.03,05/20/2015,GNRL,318640350
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.94,12/11/2015,GNRL,339491116
95528,GNRL,"Pfizer Inc.",NY,100000000286,14.78,12/23/2013,GNRL,205922302
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.78,09/30/2015,GNRL,260116866
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.65,07/24/2015,GNRL,339477144
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.57,05/09/2014,GNRL,161233128
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.51,10/20/2014,GNRL,149049136
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.46,11/07/2014,GNRL,196139062
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.35,09/09/2014,GNRL,168913758
95528,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.33,10/08/2013,GNRL,100859966
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.26,04/14/2015,GNRL,275721774
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.23,05/26/2015,GNRL,318640322
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.22,01/19/2015,GNRL,275721764
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.18,03/04/2015,GNRL,275721766
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.17,03/28/2014,GNRL,156772310
95528,GNRL,"Pfizer Inc.",NY,100000000286,14.08,10/20/2015,GNRL,323953920
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.97,10/29/2014,GNRL,198739788
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.94,11/06/2013,GNRL,12143655
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.94,02/04/2014,GNRL,198633094
95528,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.60,04/09/2015,GNRL,333361020
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.54,01/16/2015,GNRL,260059348
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.49,12/12/2013,GNRL,23817929
95528,GNRL,"SANOFI PASTEUR INC.",PA,100000000299,13.45,03/18/2015,GNRL,318740742
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.25,11/14/2014,GNRL,156772328
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.23,05/07/2014,GNRL,196138908
95528,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.20,12/15/2014,GNRL,216191834
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.19,09/02/2015,GNRL,260104956
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.18,09/27/2013,GNRL,23817923
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.18,12/04/2015,GNRL,260105468
95528,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.17,10/16/2013,GNRL,171837138
95528,GNRL,"Pfizer Inc.",NY,100000000286,13.12,04/01/2015,GNRL,322829157
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.10,09/04/2013,GNRL,12238277
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.01,08/27/2013,GNRL,12212184
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.84,08/03/2015,GNRL,260107194
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.81,01/30/2015,GNRL,332345811
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.74,01/02/2015,GNRL,269546520
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.72,10/03/2013,GNRL,23817925
95528,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.71,09/09/2015,GNRL,283394682
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.60,01/28/2015,GNRL,318640272
95528,GNRL,"LILLY USA, LLC",IN,100000000066,12.47,10/10/2014,GNRL,137810070
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.47,08/18/2015,GNRL,339349168
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.17,10/01/2014,GNRL,150671032
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.05,06/04/2014,GNRL,150300946
95528,GNRL,"Shire North American Group Inc",MA,100000061292,12.02,10/30/2015,GNRL,301027394
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.01,11/03/2014,GNRL,194686194
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.95,10/28/2015,GNRL,270034834
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.91,01/06/2014,GNRL,160800554
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.81,09/09/2013,GNRL,32303989
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.67,07/20/2015,GNRL,294902898
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.66,11/04/2013,GNRL,23817927
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.66,10/21/2014,GNRL,156772326
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.59,09/20/2013,GNRL,103326094
95528,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.57,05/22/2015,GNRL,318922961
95528,GNRL,"Pfizer Inc.",NY,100000000286,11.56,10/29/2013,GNRL,205724468
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.47,09/23/2014,GNRL,198724890
95528,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,11.46,11/17/2014,GNRL,163224484
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.44,11/24/2014,GNRL,198750908
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.37,08/23/2015,GNRL,275721770
95528,GNRL,"Amgen Inc.",CA,100000000203,11.33,10/12/2015,GNRL,297821032
95528,GNRL,"Lilly USA, LLC",IN,100000000066,11.09,02/03/2015,GNRL,268121324
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.03,06/03/2014,GNRL,198669570
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.98,10/13/2015,GNRL,295064284
95528,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.94,08/07/2013,GNRL,100859962
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.83,09/11/2015,GNRL,290146738
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.75,12/30/2014,GNRL,207346648
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.73,10/04/2013,GNRL,205040028
95528,GNRL,"Amgen Inc.",CA,100000000203,10.71,11/04/2015,GNRL,297821034
95528,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.70,02/04/2015,GNRL,260125720
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.70,09/04/2015,GNRL,337328234
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.61,10/14/2014,GNRL,207079102
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.60,11/04/2014,GNRL,196695512
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.55,08/05/2013,GNRL,32303990
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.55,09/19/2013,GNRL,13993864
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.52,01/23/2015,GNRL,290274258
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.50,12/07/2015,GNRL,332218133
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.49,02/14/2014,GNRL,206463664
95528,GNRL,"Amgen Inc.",CA,100000000203,10.42,03/02/2015,GNRL,297821030
95528,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.41,11/20/2015,GNRL,332218097
95528,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.30,09/29/2015,GNRL,319645366
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.28,12/08/2014,GNRL,196139060
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.28,10/22/2014,GNRL,196139064
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.28,01/15/2015,GNRL,322927638
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.21,04/04/2014,GNRL,196138910
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.20,08/05/2015,GNRL,269920493
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.19,02/28/2014,GNRL,206658236
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.11,08/10/2015,GNRL,290274254
95528,GNRL,"Pfizer Inc.",NY,100000000286,10.01,06/05/2014,GNRL,206414268
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.96,11/09/2015,GNRL,290274248
95528,GNRL,"Pfizer Inc.",NY,100000000286,9.96,05/15/2015,GNRL,323846162
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.91,12/03/2013,GNRL,103326090
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.84,04/06/2015,GNRL,339138664
95528,GNRL,"Pfizer Inc.",NY,100000000286,9.59,08/13/2015,GNRL,323931216
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.53,05/21/2014,GNRL,194686196
95528,GNRL,"Pfizer Inc.",NY,100000000286,9.40,08/08/2014,GNRL,205746330
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.17,05/20/2014,GNRL,196138906
95528,GNRL,"Pfizer Inc.",NY,100000000286,9.16,04/07/2015,GNRL,322461456
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.08,04/22/2015,GNRL,318640308
95528,GNRL,"Pfizer Inc.",NY,100000000286,9.05,03/13/2014,GNRL,206921876
95528,GNRL,"Pfizer Inc.",NY,100000000286,9.04,05/07/2015,GNRL,322446154
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.96,06/02/2014,GNRL,156772320
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.95,12/18/2015,GNRL,323712452
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.92,08/22/2014,GNRL,161836378
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.82,10/09/2013,GNRL,205516402
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.76,07/22/2015,GNRL,339098382
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.75,06/06/2014,GNRL,162446684
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.75,03/06/2014,GNRL,206866672
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.66,01/05/2015,GNRL,339095648
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.61,11/05/2013,GNRL,205715644
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.56,12/14/2015,GNRL,270248594
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.48,07/28/2014,GNRL,156772324
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.42,07/01/2014,GNRL,162440544
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.38,08/06/2015,GNRL,323471054
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.34,02/13/2015,GNRL,323090652
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.32,08/02/2013,GNRL,205643400
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.32,01/29/2014,GNRL,160922656
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.24,06/13/2014,GNRL,206887614
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.23,10/03/2014,GNRL,162176832
95528,GNRL,"Pfizer Inc.",NY,100000000286,8.23,01/03/2014,GNRL,206595648
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.17,09/14/2015,GNRL,270012712
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.02,04/07/2014,GNRL,156772316
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.95,02/26/2014,GNRL,196138912
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.94,02/06/2015,GNRL,269601704
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,7.86,01/07/2014,GNRL,156772314
95528,GNRL,"Pfizer Inc.",NY,100000000286,7.85,11/13/2013,GNRL,205882564
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.74,04/08/2014,GNRL,161133504
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.73,09/21/2015,GNRL,337340018
95528,GNRL,"LILLY USA, LLC",IN,100000000066,7.58,12/13/2013,GNRL,100086968
95528,GNRL,"Pfizer Inc.",NY,100000000286,7.58,07/29/2015,GNRL,323928418
95528,GNRL,"Pfizer Inc.",NY,100000000286,7.48,12/20/2013,GNRL,205642046
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.46,08/04/2014,GNRL,194686198
95528,GNRL,"Pfizer Inc.",NY,100000000286,7.42,09/19/2014,GNRL,205664160
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.34,02/02/2015,GNRL,336874042
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.15,03/24/2015,GNRL,337073422
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.06,03/23/2015,GNRL,339053712
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.91,11/23/2015,GNRL,323895232
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,6.91,03/09/2015,GNRL,318640292
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.74,08/12/2013,GNRL,205864480
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.74,02/27/2014,GNRL,206448970
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.61,09/12/2014,GNRL,206368060
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.59,04/24/2014,GNRL,205593635
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,6.51,06/23/2015,GNRL,318640356
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.15,05/22/2014,GNRL,207361478
95528,GNRL,"Pfizer Inc.",NY,100000000286,6.13,10/21/2015,GNRL,323882716
95528,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,6.10,11/17/2014,GNRL,163264918
95528,GNRL,"Pfizer Inc.",NY,100000000286,5.87,08/14/2013,GNRL,205419724
95528,GNRL,"Pfizer Inc.",NY,100000000286,5.86,11/26/2014,GNRL,205699074
95528,GNRL,"Pfizer Inc.",NY,100000000286,5.86,11/18/2015,GNRL,322683512
95528,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.81,11/24/2015,GNRL,337427366
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.81,10/20/2015,GNRL,339022038
95528,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,5.76,08/01/2013,GNRL,101994288
95528,GNRL,"Pfizer Inc.",NY,100000000286,5.62,01/15/2014,GNRL,206793360
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.58,05/11/2015,GNRL,269720482
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,5.43,11/19/2015,GNRL,318640412
95528,GNRL,"Pfizer Inc.",NY,100000000286,5.02,10/18/2013,GNRL,205221015
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.36,10/20/2015,GNRL,270024272
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.06,06/15/2015,GNRL,338977816
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.00,05/13/2014,GNRL,161242870
95528,GNRL,"Pfizer Inc.",NY,100000000286,3.99,08/24/2015,GNRL,323313516
95528,GNRL,"Pfizer Inc.",NY,100000000286,3.82,05/20/2015,GNRL,323310300
95528,GNRL,"Pfizer Inc.",NY,100000000286,3.82,11/17/2015,GNRL,323933478
95528,GNRL,"Pfizer Inc.",NY,100000000286,3.82,08/12/2015,GNRL,323960224
95528,GNRL,"Pfizer Inc.",NY,100000000286,3.25,05/18/2015,GNRL,322814778
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.14,06/16/2015,GNRL,269760594
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.95,07/28/2014,GNRL,156772334
95528,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,2.88,08/01/2013,GNRL,101994286
95528,GNRL,"Pfizer Inc.",NY,100000000286,2.59,09/15/2015,GNRL,323814286
95528,GNRL,"Pfizer Inc.",NY,100000000286,2.46,06/20/2014,GNRL,206606384
95528,GNRL,"Pfizer Inc.",NY,100000000286,2.27,12/31/2015,GNRL,323913476
95528,GNRL,"Pfizer Inc.",NY,100000000286,2.14,10/12/2015,GNRL,323574544
95528,GNRL,"Pfizer Inc.",NY,100000000286,2.14,05/12/2015,GNRL,323409326
95528,GNRL,"Pfizer Inc.",NY,100000000286,2.13,09/25/2015,GNRL,323020720
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.85,11/06/2015,GNRL,338891358
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.64,10/21/2015,GNRL,323992672
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.61,07/31/2014,GNRL,205961840
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.55,02/13/2014,GNRL,206613376
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.51,12/05/2013,GNRL,205172920
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.50,12/09/2015,GNRL,323401592
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.48,01/15/2014,GNRL,206499712
95528,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,12/21/2015,GNRL,290140488
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.47,02/13/2015,GNRL,323828494
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.46,10/29/2013,GNRL,206008235
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.46,12/04/2015,GNRL,322917978
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.44,10/13/2015,GNRL,295064416
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.40,08/08/2014,GNRL,161866731
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.34,04/23/2014,GNRL,205563242
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.29,07/28/2014,GNRL,161660550
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.28,11/26/2014,GNRL,206809238
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.18,10/09/2013,GNRL,205059712
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.18,01/28/2014,GNRL,206520056
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.17,08/14/2013,GNRL,205033132
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.13,04/07/2015,GNRL,323753882
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.09,01/28/2014,GNRL,207199856
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.08,10/09/2014,GNRL,206647076
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.08,09/12/2014,GNRL,206905786
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.06,12/20/2013,GNRL,206083360
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.03,02/10/2014,GNRL,160899438
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.03,12/14/2015,GNRL,270126885
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.00,10/06/2015,GNRL,322851292
95528,GNRL,"Pfizer Inc.",NY,100000000286,1.00,10/29/2015,GNRL,322853356
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.95,06/09/2015,GNRL,322896567
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.93,03/13/2014,GNRL,207181742
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.93,09/14/2015,GNRL,270012694
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.92,01/29/2014,GNRL,160927278
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.90,11/20/2013,GNRL,205351109
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.90,10/14/2014,GNRL,206880800
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.89,05/08/2015,GNRL,323518394
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.88,08/07/2015,GNRL,322707872
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.87,11/23/2015,GNRL,323845814
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.83,08/22/2014,GNRL,161836386
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.82,12/18/2015,GNRL,323949114
95528,GNRL,"Astellas Pharma US Inc",IL,100000000137,0.81,07/20/2015,GNRL,294902650
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.78,05/22/2014,GNRL,206380944
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.77,11/23/2015,GNRL,322908950
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.76,08/26/2015,GNRL,318640375
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.74,09/24/2014,GNRL,206285824
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.72,01/02/2015,GNRL,269546532
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.71,07/01/2014,GNRL,161702672
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.71,09/24/2014,GNRL,206199176
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.70,06/06/2014,GNRL,161474500
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.68,02/27/2014,GNRL,206973061
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.67,03/31/2015,GNRL,323875384
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.61,08/05/2015,GNRL,269919812
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.60,11/05/2013,GNRL,206090689
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.57,11/20/2013,GNRL,205905838
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.56,06/05/2014,GNRL,207172326
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.54,08/02/2013,GNRL,205154092
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.53,07/09/2014,GNRL,156772330
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.53,12/30/2014,GNRL,206476397
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.49,08/12/2013,GNRL,205305178
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.49,03/28/2014,GNRL,156772318
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.49,01/03/2014,GNRL,207198144
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.48,11/06/2015,GNRL,338861265
95528,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.45,06/02/2014,GNRL,156772322
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.45,05/10/2014,GNRL,161233138
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.45,06/24/2014,GNRL,206831132
95528,GNRL,"LILLY USA, LLC",IN,100000000066,0.44,12/13/2013,GNRL,100099234
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.41,10/04/2013,GNRL,205695456
95528,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.40,04/21/2015,GNRL,269713024
95528,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.35,06/15/2015,GNRL,338857852
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.27,07/29/2015,GNRL,322703570
95528,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.22,01/28/2015,GNRL,318640245
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.20,10/18/2013,GNRL,205724278
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.18,08/08/2014,GNRL,206832504
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.18,10/21/2015,GNRL,323502746
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.15,10/29/2013,GNRL,205566714
95528,GNRL,"Pfizer Inc.",NY,100000000286,0.10,12/15/2015,GNRL,323117576
